Its biochemical properties have been investigated in cellular, tissue and animal models, while human evidence for intranasal use remains insufficient for establishing clinical benefits, pharmacokinetics or long-term safety
For context, in one study of 175 people with overweight or obesity, participants taking semaglutide: Lost an average of 15 pounds (about 6% of their body weight) within three months Lost an average of 27 pounds (about 11% of their body weight) after six months Recommended lifestyle changes during GLP-1 therapy GLP-1 medications can boost weight loss by increasing satiety and reducing food cravings
10, 2022, Wheeler ML, Pi-Sunyer FX
It is also sensible to speak with a doctor if weight gain is rapid, if previous efforts have not worked, or if there is concern about side effects from a product already in use
Semaglutide has been structurally modified to resist degradation by the enzyme DPP-4 and to bind to albumin, extending its half-life from approximately two minutes for natural GLP-1 to about one week